$PMDI
PSYCHEMEDICS CORP

2019 Q4 Form 10-Q Financial Statement

#000117184319006773 Filed on October 24, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $8.715M $9.852M $11.02M
YoY Change -12.29% -10.57% 9.62%
Cost Of Revenue $5.230M $5.470M $5.658M
YoY Change 0.58% -3.32% 14.81%
Gross Profit $3.485M $4.382M $5.358M
YoY Change -26.37% -18.22% 4.63%
Gross Profit Margin 39.99% 44.48% 48.64%
Selling, General & Admin $3.740M $2.655M $2.866M
YoY Change 36.5% -7.36% 13.01%
% of Gross Profit 107.32% 60.59% 53.49%
Research & Development $350.0K $393.0K $372.0K
YoY Change -23.91% 5.65% 5.38%
% of Gross Profit 10.04% 8.97% 6.94%
Depreciation & Amortization $690.0K $720.0K $770.0K
YoY Change -9.21% -6.49% 8.45%
% of Gross Profit 19.8% 16.43% 14.37%
Operating Expenses $4.090M $3.048M $3.238M
YoY Change 27.41% -5.87% 12.08%
Operating Profit -$606.0K $1.334M $2.120M
YoY Change -139.66% -37.08% -5.02%
Interest Expense $0.00 $10.00K $27.00K
YoY Change -62.96% 170.0%
% of Operating Profit 0.75% 1.27%
Other Income/Expense, Net $6.000K -$9.000K
YoY Change -166.67% -169.23%
Pretax Income -$600.0K $1.340M $2.111M
YoY Change -139.47% -36.52% -5.97%
Income Tax -$70.00K $663.0K $836.0K
% Of Pretax Income 49.48% 39.6%
Net Earnings -$530.0K $677.0K $1.275M
YoY Change -160.16% -46.9% -6.52%
Net Earnings / Revenue -6.08% 6.87% 11.57%
Basic Earnings Per Share -$0.09 $0.12 $0.23
Diluted Earnings Per Share -$0.09 $0.12 $0.23
COMMON SHARES
Basic Shares Outstanding 5.517M 5.517M 5.507M
Diluted Shares Outstanding 5.517M 5.555M

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.280M $6.490M $6.020M
YoY Change -8.66% 7.81% 7.5%
Cash & Equivalents $7.283M $6.492M $6.016M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $1.790M $1.820M $1.360M
YoY Change 67.29% 33.82% 0.74%
Inventory
Prepaid Expenses
Receivables $3.780M $5.171M $8.067M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.85M $13.49M $15.44M
YoY Change -7.35% -12.66% 24.77%
LONG-TERM ASSETS
Property, Plant & Equipment $10.86M $9.139M $10.64M
YoY Change 6.73% -14.14% -13.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $943.0K $944.0K $900.0K
YoY Change 1.73% 4.89% 10.02%
Total Long-Term Assets $14.68M $13.30M $11.54M
YoY Change 32.2% 15.19% -11.72%
TOTAL ASSETS
Total Short-Term Assets $12.85M $13.49M $15.44M
Total Long-Term Assets $14.68M $13.30M $11.54M
Total Assets $27.53M $26.78M $26.99M
YoY Change 10.24% -0.75% 6.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $617.0K $372.0K $813.0K
YoY Change -9.53% -54.24% -26.29%
Accrued Expenses $3.577M $2.727M $3.908M
YoY Change 20.76% -30.22% 34.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $678.0K $416.0K $941.0K
YoY Change 62.98% -55.79% 73.62%
Total Short-Term Liabilities $5.835M $4.686M $5.662M
YoY Change 43.72% -17.24% 24.44%
LONG-TERM LIABILITIES
Long-Term Debt $1.951M $900.0K $1.719M
YoY Change 60.97% -47.64% 85.24%
Other Long-Term Liabilities $2.380M $2.360M
YoY Change
Total Long-Term Liabilities $1.951M $900.0K $1.719M
YoY Change 60.97% -47.64% 85.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.835M $4.686M $5.662M
Total Long-Term Liabilities $1.951M $900.0K $1.719M
Total Liabilities $10.71M $8.764M $8.472M
YoY Change 72.01% 3.45% 3.07%
SHAREHOLDERS EQUITY
Retained Earnings -$3.754M -$2.232M -$1.216M
YoY Change 183.11% 83.55%
Common Stock $32.28M $32.03M $31.40M
YoY Change 2.3% 2.02% 1.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M $10.08M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $668.0K $668.0K $668.0K
Shareholders Equity $16.82M $18.02M $18.51M
YoY Change
Total Liabilities & Shareholders Equity $27.53M $26.78M $26.99M
YoY Change 10.24% -0.75% 6.03%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$530.0K $677.0K $1.275M
YoY Change -160.16% -46.9% -6.52%
Depreciation, Depletion And Amortization $690.0K $720.0K $770.0K
YoY Change -9.21% -6.49% 8.45%
Cash From Operating Activities $950.0K $1.670M $410.0K
YoY Change -75.77% 307.32% -88.89%
INVESTING ACTIVITIES
Capital Expenditures -$560.0K -$760.0K -$610.0K
YoY Change 273.33% 24.59% 238.89%
Acquisitions
YoY Change
Other Investing Activities -$10.00K -$60.00K $0.00
YoY Change -99.75% -100.0%
Cash From Investing Activities -$560.0K -$830.0K -$600.0K
YoY Change -86.73% 38.33% 185.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 320.0K -1.090M -1.240M
YoY Change -115.84% -12.1% 33.33%
NET CHANGE
Cash From Operating Activities 950.0K 1.670M 410.0K
Cash From Investing Activities -560.0K -830.0K -600.0K
Cash From Financing Activities 320.0K -1.090M -1.240M
Net Change In Cash 710.0K -250.0K -1.430M
YoY Change -130.6% -82.52% -156.08%
FREE CASH FLOW
Cash From Operating Activities $950.0K $1.670M $410.0K
Capital Expenditures -$560.0K -$760.0K -$610.0K
Free Cash Flow $1.510M $2.430M $1.020M
YoY Change -62.9% 138.24% -73.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Trading Symbol
TradingSymbol
pmd
dei Entity Central Index Key
EntityCentralIndexKey
0000806517
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORP
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2978000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2806000
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5516931
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock. $0.005 par value
pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-220000
pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
1069000
CY2019Q3 pmd Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
145000
CY2019Q3 pmd Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
582000
pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
312000
pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
717000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
372000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
682000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5171000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4829000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2727000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2962000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15530000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13341000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1696000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1399000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31999000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31523000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
33000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
93000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
509000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
436000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
43000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
67000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
614000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
357000
CY2019Q3 us-gaap Assets
Assets
26784000
CY2018Q4 us-gaap Assets
Assets
24974000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
13487000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
13870000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6492000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4069000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8165000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6016000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2423000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2149000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.54
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.51
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2018Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6185000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6175000
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6185000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6175000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
31000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
31000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
347000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1095000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1775000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2357000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5470000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5658000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16004000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16853000
CY2019Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
817000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
955000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2219000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2302000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.</div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Accounting Pronouncements Issued But <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Not</div> Yet Effective</div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Income Statement &#x2013; Reporting Comprehensive Income&#x201d; (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220</div>) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which will allow a reclassification from accumulated other comprehensive income to retained earnings for the tax effects resulting from the Tax Cuts and Jobs Act (Tax Reform Act) that are stranded in accumulated other comprehensive income. This standard also requires certain disclosures about stranded tax effects. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> however, does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> change the underlying guidance that requires that the effect of a change in tax laws or rates be included in income from continuing operations. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will be effective for the Company&#x2019;s fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> with the option to early adopt prior to the effective date. It must be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. The Company is currently evaluating the impacts the adoption of this accounting guidance will have on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0 0pt 0.25in">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software: Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&#x201d;. The FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> to align the requirements for capitalizing implementation costs in a cloud computing arrangement service contract with the requirements for capitalizing implementation costs incurred for an internal-use software license. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> will be effective for the Company&#x2019;s fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> with the option to early adopt prior to the effective date. The Company is currently evaluating the impact that this updated standard will have on its consolidated financial statements.</div></div>
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
584000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-257000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1401000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1417000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1599000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4687000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4907000
CY2019Q3 us-gaap Gross Profit
GrossProfit
4382000
CY2018Q3 us-gaap Gross Profit
GrossProfit
5358000
us-gaap Gross Profit
GrossProfit
12959000
us-gaap Gross Profit
GrossProfit
15885000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1340000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2111000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3658000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6129000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
663000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
836000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1586000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2426000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1958000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2289000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-335000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
394000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
342000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3598000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
138000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
152000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
439000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
147000
us-gaap Interest Paid Net
InterestPaidNet
47000
us-gaap Interest Paid Net
InterestPaidNet
83000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3925000
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3532000
us-gaap Operating Lease Payments
OperatingLeasePayments
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
619000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
644000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1078000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
273000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
393000
CY2019Q3 us-gaap Liabilities
Liabilities
8764000
CY2018Q4 us-gaap Liabilities
Liabilities
6227000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26784000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24974000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4686000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4060000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
1316000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
416000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
416000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
416000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
380000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
416000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
104000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
900000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1212000
CY2019Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3905000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3323000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3616000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2642000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1139000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3361000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4007000
us-gaap Net Income Loss
NetIncomeLoss
2072000
us-gaap Net Income Loss
NetIncomeLoss
3703000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
677000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1275000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
30000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
65000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
3048000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3238000
us-gaap Operating Expenses
OperatingExpenses
9355000
us-gaap Operating Expenses
OperatingExpenses
9803000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1334000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2120000
us-gaap Operating Income Loss
OperatingIncomeLoss
3604000
us-gaap Operating Income Loss
OperatingIncomeLoss
6082000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1171000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2361000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
us-gaap Operating Lease Payments
OperatingLeasePayments
841000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3214000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y73D
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
944000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
927000
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-330000
CY2018Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-180000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-297000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1346000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-297000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1346000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-35000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
54000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
47000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
96000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2978000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2806000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
33000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
93000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
896000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
775000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
225000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
268000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1824000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1067000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3810000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9139000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10177000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
393000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
372000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1213000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1089000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2232000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1326000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9852000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11016000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28963000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32738000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4382000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1238000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1267000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3455000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3807000
us-gaap Share Based Compensation
ShareBasedCompensation
509000
us-gaap Share Based Compensation
ShareBasedCompensation
436000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
239000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
192000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
493000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
398000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
590000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.09
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.98
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.60
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y73D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y73D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y36D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
18747000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
18020000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
18620000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
18514000
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
668000
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5513000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5500000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10082000
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
48000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5517000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5555000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5529000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5552000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5517000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5507000
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10082000

Files In Submission

Name View Source Status
0001171843-19-006773-index-headers.html Edgar Link pending
0001171843-19-006773-index.html Edgar Link pending
0001171843-19-006773.txt Edgar Link pending
0001171843-19-006773-xbrl.zip Edgar Link pending
exh1013_01.jpg Edgar Link pending
exh1013_02.jpg Edgar Link pending
exh1013_03.jpg Edgar Link pending
exh1013_04.jpg Edgar Link pending
exh1013_05.jpg Edgar Link pending
exh1013_06.jpg Edgar Link pending
exh1013_07.jpg Edgar Link pending
exh1013_08.jpg Edgar Link pending
exh1013_09.jpg Edgar Link pending
exh1013_10.jpg Edgar Link pending
exh1013_11.jpg Edgar Link pending
exh1013_12.jpg Edgar Link pending
exh1013_13.jpg Edgar Link pending
exh1013_14.jpg Edgar Link pending
exh1013_15.jpg Edgar Link pending
exh1013_16.jpg Edgar Link pending
exh1013_17.jpg Edgar Link pending
exh1013_18.jpg Edgar Link pending
exh1013_19.jpg Edgar Link pending
exh1013_20.jpg Edgar Link pending
exh1013_21.jpg Edgar Link pending
exh1013_22.jpg Edgar Link pending
exh1013_23.jpg Edgar Link pending
exh1013_24.jpg Edgar Link pending
exh1013_25.jpg Edgar Link pending
exh1013_26.jpg Edgar Link pending
exh1013_27.jpg Edgar Link pending
exh1013_28.jpg Edgar Link pending
exh1013_29.jpg Edgar Link pending
exh1013_30.jpg Edgar Link pending
exh1013_31.jpg Edgar Link pending
exh1013_32.jpg Edgar Link pending
exh1013_33.jpg Edgar Link pending
exh_10132.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_102519p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pmd-20190930.xml Edgar Link completed
pmd-20190930.xsd Edgar Link pending
pmd-20190930_cal.xml Edgar Link unprocessable
pmd-20190930_def.xml Edgar Link unprocessable
pmd-20190930_lab.xml Edgar Link unprocessable
pmd-20190930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending